Literature DB >> 16278712

Ezetimibe (Zetia): a new type of lipid-lowering agent.

Jigna Patel1, Valerie Sheehan, Cheryle Gurk-Turner.   

Abstract

Entities:  

Year:  2003        PMID： 16278712      PMCID： PMC1200795          DOI： 10.1080/08998280.2003.11927928

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN： 0899-8280


× No keyword cloud information.
  4 in total

1.  Efficacy and safety of ezetimibe coadministered with atorvastatin or simvastatin in patients with homozygous familial hypercholesterolemia.

Authors:  Claude Gagné; Daniel Gaudet; Eric Bruckert
Journal:  Circulation       Date:  2002-05-28       Impact factor: 29.690

2.  Efficacy and safety of ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemia.

Authors:  Claude Gagné; Harold E Bays; Stuart R Weiss; Pedro Mata; Katherine Quinto; Michael Melino; Meehyung Cho; Thomas A Musliner; Barry Gumbiner
Journal:  Am J Cardiol       Date:  2002-11-15       Impact factor: 2.778

3.  Efficacy and safety of a potent new selective cholesterol absorption inhibitor, ezetimibe, in patients with primary hypercholesterolemia.

Authors:  Carlos A Dujovne; Mark P Ettinger; J Frederick McNeer; Leslie J Lipka; Alexandre P LeBeaut; Ramachandran Suresh; Bo Yang; Enrico P Veltri
Journal:  Am J Cardiol       Date:  2002-11-15       Impact factor: 2.778

4.  Efficacy and safety of ezetimibe coadministered with lovastatin in primary hypercholesterolemia.

Authors:  Boris Kerzner; John Corbelli; Stephan Sharp; Leslie J Lipka; Lorenzo Melani; Alexandre LeBeaut; Ramachandran Suresh; Pabak Mukhopadhyay; Enrico P Veltri
Journal:  Am J Cardiol       Date:  2003-02-15       Impact factor: 2.778
  4 in total
  11 in total

1.  Machine learning on drug-specific data to predict small molecule teratogenicity.

Authors:  Anup P Challa; Andrew L Beam; Min Shen; Tyler Peryea; Robert R Lavieri; Ethan S Lippmann; David M Aronoff
Journal:  Reprod Toxicol       Date:  2020-05-16       Impact factor: 3.143

Review 2.  Lipid-Lowering Therapy in Women of Childbearing Age: a Review and Stepwise Clinical Approach.

Authors:  Jelani K Grant; Sarah Snow; Michelle Kelsey; Jennifer Rymer; Anna E Schaffer; Manesh R Patel; Robert W McGarrah; Neha J Pagidipati; Nishant P Shah
Journal:  Curr Cardiol Rep       Date:  2022-07-29       Impact factor: 3.955

3.  Effect of caloric intake and macronutrient composition on intestinal cholesterol absorption and bile acids in patients with obesity.

Authors:  Anas Mohamad Hashem; Lizeth Cifuentes; Gerardo Calderon; Maria Laura Ricardo-Silgado; Daniel Gonzalez-Izundegui; Alejandro Campos; Alison McRae; Shawna Franks; Maria Daniela Hurtado; Duane Burton; Xuan-Mai Petterson; Ian R Lanza; Michael Camilleri; Andres Acosta
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2022-06-21       Impact factor: 4.871

Review 4.  Targeted Strategy in Lipid-Lowering Therapy.

Authors:  Ezgi Dayar; Olga Pechanova
Journal:  Biomedicines       Date:  2022-05-08

5.  HNF4alpha is a crucial modulator of the cholesterol-dependent regulation of NPC1L1.

Authors:  Yuki Iwayanagi; Tappei Takada; Hiroshi Suzuki
Journal:  Pharm Res       Date:  2007-12-14       Impact factor: 4.200

6.  Identification, synthesis and characterization of process related desfluoro impurity of ezetimibe and HPLC method validations.

Authors:  Esen Bellur Atici; Bekir Karlığa
Journal:  J Pharm Anal       Date:  2015-04-24

Review 7.  Flaxseed Lignans as Important Dietary Polyphenols for Cancer Prevention and Treatment: Chemistry, Pharmacokinetics, and Molecular Targets.

Authors:  S Franklyn De Silva; Jane Alcorn
Journal:  Pharmaceuticals (Basel)       Date:  2019-05-05

8.  Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes.

Authors:  Matthew T Roe; Qian H Li; Deepak L Bhatt; Vera A Bittner; Rafael Diaz; Shaun G Goodman; Robert A Harrington; J Wouter Jukema; Patricio Lopez-Jaramillo; Renato D Lopes; Michael J Louie; Patrick M Moriarty; Michael Szarek; Robert Vogel; Harvey D White; Andreas M Zeiher; Marie T Baccara-Dinet; Ph Gabriel Steg; Gregory G Schwartz
Journal:  Circulation       Date:  2019-09-02       Impact factor: 29.690

9.  Formulation and Evaluation of Linum usitatissimum Mucilage-Based Nanoparticles for Effective Delivery of Ezetimibe.

Authors:  Ume Ruqia Tulain; Arshad Mahmood; Sidra Aslam; Alia Erum; Nadia Shamshad Malik; Ayesha Rashid; Rizwana Kausar; Mohammed S Alqahtani
Journal:  Int J Nanomedicine       Date:  2021-07-05

10.  Mitotane-induced hyperlipidemia: a retrospective cohort study.

Authors:  Hassan Shawa; Ferhat Deniz; Hadil Bazerbashi; Mike Hernandez; Rena Vassilopoulou-Sellin; Camilo Jimenez; Mouhammed Amir Habra
Journal:  Int J Endocrinol       Date:  2013-11-14       Impact factor: 3.257
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.